There are over 100 HPV strains recognized in the human body. But only a select few of these strains are highly cancerous. These are the strains I would suggest research increased. They are known as HPV 16, 18, 31, and 45. They are known as high-risk.
HPV is now recognized as the human cancer virus responsible for causing virtually all cases of cervical cancer in women, with the high-risk HPVs 16, 18, 31 and 45 accounting for up to ~80% of cervical cancer. HPV types 33, 35, 39, 51 52, 56 58 and 59 are also associated with cervical cancer and several other types have been classified as “probably carcinogenic to humans” or “possibly carcinogenic”
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. A review of human carcinogens–Part B: biological agents. Lancet Oncol. 2009; 10:321–322. [PubMed: 19350698]
Treatment options are currently available to reduce the spread of strains 16 and 18 and were introduced in 2018. They are expected to relieve the majority of the HPV infection burden on our population over time and with continued and consistent use.
